Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on June 24, 2026

Jun. 24, 2026

VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development

Indeterminate GlobeNewswire

Jun. 24, 2026

TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Indeterminate GlobeNewswire

Jun. 24, 2026

PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

Indeterminate GlobeNewswire

Jun. 24, 2026

MapLight Therapeutics Announces Changes to Board of Directors

Indeterminate GlobeNewswire

Jun. 24, 2026

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

Indeterminate GlobeNewswire

Jun. 24, 2026

Helus Pharma™ Announces US$50 Million Underwritten Offering

Indeterminate GlobeNewswire

Jun. 24, 2026

NEW REPORT: Ten Years After Their Promises, Canada's Biggest Food Companies Are Still Failing Millions of Animals

Indeterminate GlobeNewswire

Jun. 24, 2026

Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress

Indeterminate GlobeNewswire

Jun. 24, 2026

RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention

Indeterminate GlobeNewswire

Jun. 24, 2026

FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing

Indeterminate GlobeNewswire

Jun. 24, 2026

MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering

Indeterminate GlobeNewswire

Jun. 24, 2026

uniQure Announces Pricing of Upsized $225 Million Public Offering

Indeterminate GlobeNewswire